About Farcast Biosciences
Farcast Biosciences is a company based in Madison (United States) founded in 2009 by Pradip K Majumder, Padhma Radhakrishnan, and Shiladitya Sengupta. Farcast Biosciences has raised $88.14 million across 5 funding rounds from investors including Tata Capital, Accel and RA Capital. The company has 30 employees as of October 31, 2024. Farcast Biosciences offers products and services including TruTumor, TruPower, and Farcast Biodynamics System.
- Headquarter Madison, United States
- Employees 30 as on 31 Oct, 2024
- Founders Pradip K Majumder, Padhma Radhakrishnan, Shiladitya Sengupta
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.14 M (USD)
in 5 rounds
-
Latest Funding Round
$43.82 M (USD), Series C
Jul 11, 2018
-
Investors
Tata Capital
& 15 more
-
Employee Count
30
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Farcast Biosciences
Farcast Biosciences offers a comprehensive portfolio of products and services, including TruTumor, TruPower, and Farcast Biodynamics System.
System for testing cancer therapies in preserved tumor contexts.
Platform for generating AI-driven predictive biosignatures.
Analyzes tumor data to forecast treatment responses accurately.
Funding Insights of Farcast Biosciences
Farcast Biosciences has successfully raised a total of $88.14M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $43.82 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Farcast Biosciences
Farcast Biosciences has secured backing from 16 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Tata Capital, Accel and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Locked | Locked | Locked | |
|
Accel is recognized as a leading venture capital firm.
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for Farcast Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Farcast Biosciences
Investment portfolio details for Farcast Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Farcast Biosciences
Detailed financials for Farcast Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Farcast Biosciences Comparisons
Peer comparison for Farcast Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Farcast Biosciences
Detailed competitors of Farcast Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Farcast Biosciences
Complete news archive for Farcast Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Farcast Biosciences
Farcast Biosciences was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Farcast Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Mohit Malhotra is the current CEO of Farcast Biosciences.
Farcast Biosciences is a funded company, having raised a total of $88.14M across 5 funding rounds to date.
As of Oct 31, 2024, the latest employee count at Farcast Biosciences is 30.
Founded in 2009 and based in Madison, United States, the biotechnology firm specializes in anthropic biological systems, data, and an AI platform. Complexity of human tumors and autologous blood samples is captured through culturing that preserves the microenvironment, tumor architecture, and immune cell compartment. Ex vivo evaluations of tumor responses to drug treatments are enabled by these operations in the oncology sector.
Farcast Biosciences offers TruTumor, TruPower, and Farcast Biodynamics System.
Farcast Biosciences has 16 investors. Key investors include Tata Capital, Accel, RA Capital, KITVEN, and India Innovation Fund.